Try a review on the sample project.

Eight findings from a short review article. Filter by AI suggestion, open a finding to see its passage, and make the decisions yourself. Nothing here is saved.

Illustrative sample. Statements, sources and passages are invented for this demonstration; in RefPack they come from your manuscript and your reference PDFs.

Review

Approving against the AI, rejecting, or marking a source unavailable asks for a reason, just as it does in RefPack.

Sample project · GvHD review8 findings · 6 decided

Statement · manuscript p. 1

Chronic GvHD remains the leading cause of late non-relapse mortality after allogeneic stem cell transplantation.¹

SupportedAI suggestion · your decision is separate

The passage states the same finding.

reference-01.pdfp. 3 of 14

In long-term survivors of allogeneic haematopoietic cell transplantation, chronic GvHD is the leading cause of late non-relapse mortality and a major cause of morbidity.

Your decision

Statement · manuscript p. 1

Extracorporeal photopheresis has emerged as a second-line therapy for steroid-refractory chronic GvHD.^2,3

SupportedAI suggestion · your decision is separate

The passage supports the statement. Reference 3 is checked as a separate finding.

reference-02.pdfp. 4 of 9

ECP is an established second-line option for patients with steroid-refractory chronic GvHD, particularly with skin and mucosal involvement.

Your decision

Statement · manuscript p. 1 · second source

Extracorporeal photopheresis has emerged as a second-line therapy for steroid-refractory chronic GvHD.^2,3

SupportedAI suggestion · your decision is separate

The second source also supports the statement.

reference-03.pdfp. 2 of 12

Photopheresis is recommended as second-line therapy in steroid-refractory chronic GvHD in current consensus guidance.

Your decision

Statement · manuscript p. 2

The response rate of ECP in acute GvHD exceeds 80% in most studies.⁵

Partly supportedAI suggestion · your decision is separate

The source reports 50% to 80%, depending on the organs involved. "Exceeds 80%" overstates it.

reference-05.pdfp. 5 of 11

Overall response rates to ECP in steroid-refractory acute GvHD ranged from 50% to 80%, with the highest responses in skin involvement and lower rates in gastrointestinal and liver disease.

Your decision

Statement · manuscript p. 3

No significant adverse effects were associated with long-term ECP in paediatric patients.⁶

Not supportedAI suggestion · your decision is separate

The source reports adverse events in children; the statement says there were none.

reference-06.pdfp. 7 of 8

Adverse events in children were mostly mild, including catheter-related complications and transient hypotension.

Your decision · reason: Source reports adverse events

Statement · manuscript p. 3

ECP allows corticosteroid doses to be reduced in most patients with chronic GvHD.⁷

No PDFNot checked

Reference 7 has no PDF, so nothing could be checked. It is listed as not available in the pack.

reference-07no file

No PDF is attached to this reference. Add it in Prepare, or mark the source as not available with a reason.

Your decision · reason: Requested from the library

Statement · manuscript p. 4

Response to ECP does not depend on the number of organs involved.⁸

No passage foundAI suggestion · your decision is separate

No passage about organ involvement was found in this PDF. Check the source yourself, or select the passage if it is there.

reference-08.pdfp. 1 of 6

Patients received ECP twice weekly for 12 weeks, then every two weeks until response. Responses were assessed at weeks 12 and 24…

Your decision

Illustrative sample. Your decisions here are not saved.

Deliver

When the findings are decided, RefPack builds the reference pack: the annotated manuscript, the annotated source PDFs, the evidence table and a list of exceptions, in one ZIP file.

What's in the pack

Reference packGvHD review

Cover sheetPDF
Annotated manuscript6 statements
Annotated sources7 PDFs
Evidence table8 rows
Not available1 reference
Exceptions2

reference-02.pdf · annotatedp. 4

Photopheresis in steroid-refractory chronic GvHD

Management of steroid-refractory disease remains difficult, and no single second-line agent is preferred for all patients.

ECP is an established second-line option for patients with steroid-refractory chronic GvHDRef 2 · F-02, particularly with skin and mucosal involvement.

Responses are usually assessed after three months of treatment, and therapy is tapered once a stable response is reached.

The same three steps with your own manuscript

Prepare. Add your manuscript and reference PDFs; RefPack finds each cited statement and matches its source.
Review. Check each finding with the passage in view, with or without AI search.
Deliver. Create the reference pack from your decisions.

Run the same check on your own manuscript.

Get started free Talk to us about teams

Try a review on the sample project.

Eight findings from a short review article. Filter by AI suggestion, open a finding to see its passage, and make the decisions yourself. Nothing here is saved.

Illustrative sample. Statements, sources and passages are invented for this demonstration; in RefPack they come from your manuscript and your reference PDFs.